Kirill Osipov comments on regulation of dependent inventions in Russia June 14, 2018 Kirill Osipov, the Head of Legal Department of ARS-Patent, commented on regulation of dependent inventions in Russia for the newspaper “Pharmvestnik” in the light of the Moscow Arbitration Court’s Decision of June 1, 2018, according to which, a first compulsory license may be granted in Russia to a medicament comprising INN Lenalidomide. More details are available at Pharmvestnik’s website. Pharmvestnik is the leading specialized weekly newspaper covering the Russian pharmaceutical and related industries with a circulation of 16 200 copies. The newspaper has been issued since 1994. Make an enquiry
MEET WITH US ARS-Patent will attend the APAA 2025 in Kuala Lumpur2025-10-03We are pleased to announce that ARS-Patent will be a part of the upcoming global IP event APAA 2025, which is the 21st General Assembly and 77th & 78t...Read moreARS-Patent at AIPPI World Congress 2025 in Yokohama2025-08-18The AIPPI World Congress 2025, which will be held in Yokohama, Japan, from September 13-16, will be a significant international gathering for intellec...Read moreSee all Events
ARS-Patent will attend the APAA 2025 in Kuala Lumpur2025-10-03We are pleased to announce that ARS-Patent will be a part of the upcoming global IP event APAA 2025, which is the 21st General Assembly and 77th & 78t...Read more
ARS-Patent at AIPPI World Congress 2025 in Yokohama2025-08-18The AIPPI World Congress 2025, which will be held in Yokohama, Japan, from September 13-16, will be a significant international gathering for intellec...Read more
